A research team led by Dr. Àlex Bayés, Head of the Molecular Physiology of the Synapse Group at the Institut de Recerca Sant ...
GRIN2A gene mutations emerge as single-gene cause of childhood schizophrenia, anxiety, and mood disorders, potentially ...
SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, unveiled new data today on ...
Overall, tucatinib add-on to first-line maintenance therapy for HER2-positive metastatic breast cancer delayed progression by ...
SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, has unveiled new data on a ...
Sugar cravings naturally reduce as people grow older. This happens not just because of food preferences but also biological ...
Introducing Ozempic, a groundbreaking GLP-1 agonist now making waves in India! This innovative treatment emulates a natural ...
Zealand Pharma may be gearing up for a high-stakes year of obesity readouts, but the Danish biopharma thinks the brain could hold the key to the company’s long-term success. | Zealand Pharma may be ...
Saffron is a spice high in antioxidants and anti-inflammatory compounds. It may have benefits for mood, cognitive function, heart health, and more.
Is it bad to have a cup of coffee with breakfast? Not at all. Scientific studies have been highlighting the benefits of this ...
A neurology nurse explains what we’re learning about Ozempic, GLP-1s, mood, cravings, brain fog, and long-term risks.
A peripherally acting cannabinoid receptor 1 antibody combined with semaglutide induced significant weight loss for adults ...